NIH-funded research R01 grant

Whole genome sequencing to uncover molecular causes in nephrotic syndrome

Official title: Whole Genome Sequencing for Nephrotic Syndrome Discovery

Funded at Boston Children's Hospital · NIH-11447299 · Data updated 2026-11-12

A study to map the genetic and molecular factors behind nephrotic syndrome and related kidney diseases to help diagnose and guide future treatments for patients.

More Nephrotic Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 18, 2019
Project endMay 31, 2031
Funding year2026
Award (this year)$892,646
NIH project number2R01DK119380-07A1
Project IDNIH-11447299 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with nephrotic syndrome or related proteinuric kidney diseases, including both pediatric and adult patients, whose kidney tissue and genomic data are available for study.

Less likely to help

Patients without access to genomic or kidney tissue data or those not meeting study criteria may not benefit directly.

What this research studies

This project uses whole genome sequencing and kidney tissue RNA data from people with proteinuric kidney diseases to build a detailed map of how these conditions arise at the molecular level. Researchers integrate genetic information with other patient data to identify the specific pathways that drive disease, aiming to point toward more precise and effective therapies. The work builds on prior findings about immune and kidney dysfunction in these conditions and looks for genetic signals that explain differences between patients. If successful, the results could lead to better diagnostics and targeted treatments for individuals with NS.

Why it matters

Potential benefit: New molecular insights may enable earlier and more accurate diagnosis and guide development of targeted therapies for nephrotic syndrome.

How similar studies have gone: Previous work has shown that integrating genomic and transcriptomic data can reveal disease mechanisms, supporting the potential of this approach.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Sampson, Matthew Gordon — Boston Children's Hospital
  • Study coordinator: Sampson, Matthew Gordon

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.